Evidence map›Paper›PMID 35805079›Full record

ArticleCells2022

Osteoblasts in a Perfusion Flow Bioreactor-Tissue Engineered Constructs of TiO

Maria Schröder, Janne Elin Reseland, Håvard Jostein Haugen

Abstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Frontiers in bioengineering and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maria SchröderDepartment of Biomaterials, Institute of Clinical Dentistry, University of Oslo, NO-0317 P.O. Box 1109 Blindern Oslo, Norway.
Janne Elin ReselandDepartment of Biomaterials, Institute of Clinical Dentistry, University of Oslo, NO-0317 P.O. Box 1109 Blindern Oslo, Norway.ORCID 0000-0001-5743-4297
Håvard Jostein HaugenDepartment of Biomaterials, Institute of Clinical Dentistry, University of Oslo, NO-0317 P.O. Box 1109 Blindern Oslo, Norway.ORCID 0000-0002-6690-7233

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combining biomaterial scaffolds with cells serves as a promising strategy for engineering critical size defects; however, homogenous cellular growth within large scaffolds is challenging. Mechanical stimuli can enhance bone regeneration by modulating cellular growth and differentiation. Here, we compare dynamic seeding in a perfusion flow bioreactor with static seeding for a synthetic bone scaffold for up to 21 days using the cell line MC3T3-E1 and primary human osteoblast, confocal laser scanning microscopy, and real-time reverse transcriptase-polymerase chain reaction. The secretion of bone-related proteins was quantified using multiplex immunoassays. Dynamic culture improved cellular distribution through the TiO

Indexed as

Tissue EngineeringVascular Endothelial Growth Factor ABioreactorsHumansOsteoblastsPerfusionTitaniumTitaniumtitanium dioxideVascular Endothelial Growth Factor Abone tissue engineeringfluid flowhuman osteoblastsperfusion bioreactorsynthetic bone scaffoldwall shear stress

Identifiers

PMID35805079
PMCPMC9265932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.